Gentex
Gentex's revenue rose 9.6% to $2.5 billion in fiscal 2025. Its operating margin was 18.7%, down from 19.9% a year earlier. Free cash flow was $458 million, up 29.6%. It paid out $422 million in dividends and buybacks, 92% of free cash flow. The diluted share count fell 3.6%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2016 to 2025, earnings per share grew 4.3% a year and net income 1.1% a year, as buybacks cut the share count by 25%.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value Gentex yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Gentex's 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from Gentex's fiscal 2025 free cash flow of $458M, net cash of $147M at December 31, 2025 and 218 million diluted shares, from its filings. The scenarios are fitted to Gentex: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, 9.7% a year; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 12%: 11% for a cyclical or higher-risk business (Automotive Parts & Equipment), plus 1 point as a smaller company, worth $4.3B; the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $20.64
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
Value per share on three example scenarios, from Gentex's earnings per share of $1.89 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 16.6×, the middle of Gentex's own P/E today, its peers' median and its sector's median (its peers' median) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 13%, 12% and 11%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $20.64
- Value at this multiple, against the last close
- —
- Gentex's P/E at the last close
- 10.9×
| Company | Last close | Earnings per share | P/E today |
|---|---|---|---|
| Dorman ProductsDORM | $124.74 | $7.22 | 17.3× |
| Standard Motor ProductsSMP | $37.28 | $2.24 | 16.6× |
| VisteonVC | $75.70 | $5.80 | 13.1× |
| GentexGNTX | $20.64 | $1.89 | 10.9× |
Balance sheet
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 268 | 238 | 241 | 256 | 151 |
| Debt incl. finance leases | 0 | 0 | 0 | 0 | 4 |
| Net debt (negative means net cash) | −268 | −238 | −241 | −256 | −147 |
| Net debt to EBITDA | −0.5x | −0.5x | −0.4x | −0.5x | −0.2x |
| Debt to equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | — | — | — | — | — |
| Current ratio | 4.8x | 3.8x | 3.7x | 4.1x | 2.9x |
| Quick ratio | 3.1x | 2.2x | 2.2x | 2.4x | 1.6x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, no insider bought Gentex shares on the open market, and 8 insiders sold $2.7 million.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| May 15, 2026 | Brian C WalkerDirector | Sold | 5,939 | $22.98 | $136,478 | Form 4 |
| May 5, 2026 | Leslie L BrownDirector | Sold | 10,782 | $22.85 | $246,369 | Form 4 |
| Apr 30, 2026 | Richard O SchaumDirector | Sold | 4,815 | $23.31 | $112,238 | Form 4 |
| Feb 17, 2026 | Steven R DowningPresident and CEO | Sold | 35,000 | $24.75 | $866,250 | Form 4 |
| Feb 17, 2026 | Matthew ChiodoVice President of Sales | Sold | 19,827 | $25.03 | $496,270 | Form 4 |
| Feb 17, 2026 | Kevin C NashChief Financial Officer | Sold | 11,885 | $24.98 | $296,887 | Form 4 |
| Feb 17, 2026 | Neil BoehmChief Technology Officer | Sold | 11,248 | $24.82 | $279,175 | Form 4 |
| Feb 17, 2026 | Scott P RyanGeneral Counsel | Sold | 9,024 | $24.73 | $223,164 | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Pass | Fail | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Fail | Fail | Fail |
| Current ratio rose | Fail | Pass | Fail |
| Share count didn't rise | Pass | Pass | Pass |
| Gross margin rose | Pass | Pass | Pass |
| Revenue rose relative to assets | Pass | Fail | Pass |
| F-score | 7 of 9 | 6 of 9 | 6 of 9 |
| Accruals ratio | −4.4% | −3.5% | −7.1% |
Compare
Put Gentex side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Gentex | FY25 | 9.6% | 18.7% | 18.1% | 17.4% | −0.2x | 6 | |
| Dorman Products | FY25 | 6.0% | 14.1% | 3.5% | 12.4% | 1.2x | 8 | Compare |
| Mobileye | FY25 | 14.5% | −23.2% | 27.6% | — | — | — | Compare |
| Standard Motor Products | FY25 | 22.4% | 7.6% | 1.0% | 8.2% | 3.0x | 7 | Compare |
| Visteon | FY25 | −2.5% | — | — | 19.3% | −1.0x | 7 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 1,679 | 1,795 | 1,834 | 1,859 | 1,688 | 1,731 | 1,919 | 2,299 | 2,313 | 2,534 |
| Revenue growth | 8.8% | 6.9% | 2.2% | 1.4% | −9.2% | 2.5% | 10.8% | 19.8% | 0.6% | 9.6% |
| Gross profit | 668 | 694 | 690 | 688 | 605 | 620 | 610 | 763 | 771 | 867 |
| Research and development | 94 | 100 | 107 | 115 | 116 | 118 | 133 | 154 | 182 | 203 |
| Operating income | 512 | 523 | 508 | 488 | 400 | 410 | 370 | 496 | 460 | 474 |
| Net income | 348 | 407 | 438 | 425 | 348 | 361 | 319 | 428 | 404 | 385 |
| Diluted EPS (US$) | 1.19 | 1.41 | 1.62 | 1.66 | 1.41 | 1.50 | 1.36 | 1.84 | 1.76 | 1.74 |
| Diluted shares (millions) | 291 | 288 | 270 | 253 | 244 | 237 | 231 | 230 | 226 | 218 |
| Cash flow | ||||||||||
| Cash from operations | 477 | 501 | 552 | 506 | 464 | 362 | 338 | 537 | 498 | 587 |
| Capital expenditure | 121 | 104 | 86 | 85 | 52 | 69 | 146 | 184 | 145 | 129 |
| Free cash flow | 356 | 397 | 466 | 421 | 413 | 293 | 192 | 354 | 354 | 458 |
| Dividends paid | 101 | 109 | 117 | 116 | 117 | 115 | 113 | 112 | 110 | 107 |
| Share buybacks | 163 | 231 | 592 | 332 | 288 | 325 | 112 | 147 | 206 | 316 |
| Acquisitions | 0 | 0 | 0 | 0 | 11 | 12 | 0 | 19 | 3 | 156 |
| Stock-based compensation | 19 | 18 | 18 | 22 | 31 | 27 | 30 | 39 | 40 | 37 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 724 | 722 | 386 | 437 | 450 | 268 | 238 | 241 | 256 | 151 |
| Debt incl. finance leases | 178 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
| Total assets | 2,310 | 2,352 | 2,085 | 2,169 | 2,198 | 2,131 | 2,327 | 2,611 | 2,761 | 2,929 |
| Total liabilities | 399 | 302 | 224 | 231 | 234 | 193 | 261 | 299 | 289 | 438 |
| Shareholders' equity | 1,910 | 2,050 | 1,862 | 1,938 | 1,964 | 1,938 | 2,066 | 2,312 | 2,468 | 2,488 |
| Margins and ratios | ||||||||||
| Gross margin | 39.8% | 38.7% | 37.6% | 37.0% | 35.9% | 35.8% | 31.8% | 33.2% | 33.3% | 34.2% |
| Operating margin | 30.5% | 29.2% | 27.7% | 26.3% | 23.7% | 23.7% | 19.3% | 21.6% | 19.9% | 18.7% |
| Net margin | 20.7% | 22.7% | 23.9% | 22.9% | 20.6% | 20.8% | 16.6% | 18.6% | 17.5% | 15.2% |
| Free cash flow margin | 21.2% | 22.1% | 25.4% | 22.7% | 24.4% | 16.9% | 10.0% | 15.4% | 15.3% | 18.1% |
| Return on capital | 25.3% | 29.7% | 30.4% | 27.9% | 22.4% | 22.3% | 18.2% | 21.6% | 18.4% | 17.4% |
| Return on equity | 19.1% | 20.6% | 22.4% | 22.4% | 17.8% | 18.5% | 15.9% | 19.6% | 16.9% | 15.5% |
| Return on assets | 15.6% | 17.4% | 19.7% | 20.0% | 15.9% | 16.7% | 14.3% | 17.4% | 15.1% | 13.5% |
| Net debt to EBITDA | −0.9x | −1.2x | −0.6x | −0.7x | −0.9x | −0.5x | −0.5x | −0.4x | −0.5x | −0.2x |